Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grosvenor Health & Life Sciences is the dedicated investment and operating arm of Grosvenor, a privately owned international property and investment group. The firm focuses on backing and building innovative companies that address significant unmet needs in human health through advanced science and technology. Their investment strategy is characterized by a long-term, patient capital approach, supporting businesses across the life sciences, diagnostics, and health technology sectors. Grosvenor Health & Life Sciences partners with management teams to scale high-impact organizations, with a portfolio that includes leaders in microbiome science, fibroblast biology, and RNA therapeutics. By providing both capital and strategic guidance, the firm aims to foster sustainable growth and deliver transformative healthcare solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grosvenor Funds.